Thiamine Deficiency Leading to Refractory Lactic Acidosis in a Pediatric Patient

Alicia M Teagarden1, Brian D Leland1, Courtney M Rowan1

  • 1Section of Pediatric Critical Care Medicine, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.

Insights

Thiamine deficiency can cause severe lactic acidosis in critically ill patients, even neonates. Prompt vitamin supplementation rapidly resolved the condition in a case of severe pertussis.

Area of Science:

  • Biochemistry
  • Pediatric Critical Care

Background:

  • Thiamine (vitamin B1) is essential for cellular energy metabolism.
  • Thiamine deficiency can lead to severe lactic acidosis and increased mortality in critically ill individuals.
  • Lactic acidosis in neonates often presents diagnostic challenges.

Observation:

  • A term neonate with malignant pertussis, requiring extracorporeal membrane oxygenation and continuous renal replacement therapy, developed profound lactic acidosis.
  • Extensive evaluations failed to identify the etiology of the lactic acidosis.
  • The neonate was ultimately diagnosed with thiamine deficiency.

Findings:

  • Thiamine deficiency was the underlying cause of severe lactic acidosis in this critically ill neonate.
  • Vitamin B1 supplementation led to a rapid resolution of the lactic acidosis.
  • This case highlights a rare but critical complication of thiamine deficiency.

Implications:

  • Thiamine deficiency should be considered in the differential diagnosis of unexplained lactic acidosis in critically ill neonates.
  • Early diagnosis and treatment of thiamine deficiency can prevent severe metabolic derangements and improve outcomes.
  • This case underscores the importance of assessing vitamin status in critically ill pediatric patients.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
932
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
258
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
289
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
334
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
4.4K